Global precision medicine market size and share revenue is anticipated to reach around $86.25 billion by 2025, growing at a CAGR of around 10.1%.
Precision Medicine Market
The report covers a forecast and an analysis of the precision medicine market on a global and regional level. The study provides historical data from 2016 to 2018The along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes the drivers and restraints of the precision medicine market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the precision medicine market on a global and regional level.
In order to give the users of this report a comprehensive view of the precision medicine market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides a company market share analysis to give a broader overview of the key players in the precision medicine market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the precision medicine market on a global and regional basis.
The study contributes a conclusive view of the precision medicine market by segmenting the market based on technology, application, end-user, and region. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Some major players of the precision medicine market are Eagle Genomics, Biocrates Life Sciences, Teva Pharmaceuticals, Novartis, Quest Diagnostics, Qiagen, Silicon Biosystems, NanoString Technologies, Ferrer inCode, Laboratory Corporation of America Holdings, Pfizer, Hoffmann-La Roche, and Tepnel Pharma Services.
This report segments the global precision medicine market into: